Skip to the story

Vol. I · No. 1

Morning ColumnThe letter

Current News · Sourced report

STAT+: Pharmalittle: We're reading about Overton FDA nomination being yanked, a Merck setback, and more

A report from STAT. The headline is the source headline.

News Desk · Nov 18, 2026 · STAT

Open the source

This page records a report from STAT. The source date is Nov 18, 2026.

The headline above is the source headline. Morning Column does not republish the article. Read the report at the source.

This page is general information from the sources below. It is not personal medical advice, a diagnosis, or a treatment plan. Talk with a qualified clinician about your own health. Read the disclaimer.

References

  1. STAT. STAT+: Pharmalittle: We're reading about Overton FDA nomination being yanked, a Merck setback, and more. Nov 18, 2026.

See a factual error? Write to contact@morningcolumn.com. The corrections log is public.